• Khan S, Asghari R, Lin M. An unusual presentation: breast metastases imitating a gastric primary- first Australian case reported. Intern Med J 2018; 885-6
  • Naik N, Lin M, Lin P. Primary genitourinary lymphoma on FDG-PET. Br J Radiol 2018; 11:20170273.
  • Eslick R, Dunlop L, Lin M, et al. The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma. Blood Cancer J 2017; 21; 7(4):e556.
  • Manoharan V, Lee S, Chong S, Yap J, Coupe N, Wilson R, Merrett N, Ng W, Lin M. Serial imaging using [18F] Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy. Ann Nucl Med 2017; 31(4):315-323.
  • Huang YT, Park J, Chong S, Hugh TJ, Ng WL, Lin M. The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis. Asia Pac J Clin Oncol 2017;13(5):e262-e270.
  • Min M, Lin P, Liney G, et al. A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy. J Med Imaging Radiat Oncol 2017; 61(1):99-123.
  • Lin P, Min M, Lee M, et al. Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site. Radiother Oncol, 2016; 120(1):87-91.
  • Lin P, Min M, Lee M, et al. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. European Journal of Nuclear Medicine and Molecular Imaging 2016; 1-11.
  • Min M, Lin P, Lee M, et al. 18F-FDG PET–CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other? J Med Imaging Radiat Oncol 2016; 60 (3):433-40.
  • Min M, Lee MT, Lin P, et al. Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R 2*) with 18F-FDG-PET in patients with head and neck cancer treated with radiation therapy. Br J Radiol, 2016; 89(1058):20150530.
  • Min M, Lin P, Lee M, et al. Prognostic Value of 2-[18F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan carried out during and after radiation therapy for head and neck cancer using Visual Therapy Response Interpretation Criteria. Clinical Oncology, 2016; 28 (6):393-401.
  • Wang Duo, Koh ES, Descaller J, et al. Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with nonsmallcell lung cancer. Asia Pacific Journal of Clinical Oncology, 2016; 12.4: 349-358.
  • Yap J, Huang YT, Lin M.  Detection of synchronous gastric schwannoma on FDG-PET/CT in a patient aided by discordant metabolic response. Clin Nucl Med 2015; 40(5):287-9.
  • Huang, YT, Wu P, Chong S, Ho Shon I, Lin P, Lin M, Time-of-flight PET/CT in mediastinal staging of Non-small Cell Lung Cancer. Intern Med J, 2015; 45: 7-8.
  • Bahure S, Cheung J, Lin M. Utility of FDG-PET in primary renal lymphoma. Clin Exp Nephrol 2015; 19(1):158-9.
  • Devadas M, Mittal A, Lin M, et al. FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers. International Journal of Surgery2015; 113-117.
  • Lin P, Stoakes E, Scott A, et al. Clinical Impact of FDG PET-CT carried out for non-medicare eligible indications in Australia: A Prospective Study. Clinical Oncology 2015; 27(12):753–754.
  • Min M, Lin P, Lee MT, et al. Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2015; 42(13):1984-94.
  • Book Chapter:  Lin M, Kumar D. Imaging of tumour metabolism: 18-FDG PET. In: Functional Imaging in Oncology. Edited by A. Luna, J. C. Vilanova, L. C. Hygino Da Cruz and S. Rossi. Springer-Verlag, 2014.
  • Book Chapter: Park D, Ho Shon I., Hua M, et al. (2014). Visualization of proteins and cells using dithiol-reactive metal complexes. In G. Gasser (Ed.), Inorganic Chemical Biology: Principles, Techniques and Applications (pp. 215-232). John Wiley & Sons.
  • Sidhu P, Lin P, Son H, Rosenfeld D, Lin M. Testicular 18-fluoro-2-deoxy-D-glucose uptake on positron emission tomography CT in patients with lymphoma: Clinical significance and management impact. Br J Radiol 2014; 87(1044).
  • Zhou L, Lin M, Downe P, et al. The prognostic value of mid- and post-treatment [18F]fluorodeoxyglucose (FDG) Positron Emission Tomography in indolent follicular lymphoma. Ann Nucl Med 2014; 28(8):805-811.
  • Coupe N, Karikios D, Chong S, Yap J, Ng W, Merrett N, Lin M. Metabolic information on staging FDG PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer. Ann Nucl Med 2014; 28(2):128-35.
  • Lin M, Wong VW, Yap J, et al. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index. Clin Imaging 2013; 37(6):1084-1088.
  • Lin M, Ambati C. The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): An analysis of 649 cases. Lung Cancer 2012; 76(3)344-349.
  • Sam S, Ho Shon I, Vinod SK, Lin P, Lin M. Workflow and radiation safety implications of 18FDG-PET/CT scans for radiotherapy planning. J Nucl Med Technology 2012.
  • Wong C, Lin M, Chicco A, et al. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy. Acta Radiologica 2011;52: 899–904.
  • Lin P, Koh ES, Lin M, et al. Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer. Radiother Oncol 2011;101(2):284-290.
  • Lin M, Wong K, Ng WL, et al. Positron emission tomography and colorectal cancer. Crit Rev Oncol Hematol 2011; 77:30-47.
  • Lin M, Wong C, Lin P, Shon IH, et al. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Hematol Oncol 2011; 29:67-74.
  • Ho Shon I, Depcynzski B, Lin M, et al. Positron emission tomography in non-medullary thyroid cancer. ANZ J Surg 2011; 81:116-24.
  • Lin M, Koo JH, Abi-Hanna D. Management of patients following detection of unsuspected colon lesions by PET imaging. Clin Gastroenterol Hepatol 2011;9(12):1025-1032.
  • Lin M. Molecular imaging using Positron Emission Tomography in colorectal cancer. Discov Med 2011; 11(60):435-447.
  • London K, Lin M. Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer. [Letter]. Ann Surg Oncol 2011; 18(1):291.
  • Yap ML, Vinod SK, Shon IH, Fowler A, Lin M, Gabriel G, Holloway LC. The registration of diagnostic versus planning fluorodeoxyglucose positron emission tomography/computed tomography in radiotherapy planning for non-small cell lung cancer. Clin Oncol (R Coll Radiol) 2010; 22:554-60.
  • Sathiakumar C, Som S, Eberl S, Lin P. NEMA NU 2-2001 performance testing of a Philips Gemini GXL PET/CT scanner. Australas Phys Eng Sci Med 2010; 33:199-209.
  • Lin M, Shon IH, Lin P. Positron emission tomography: current status and future challenges. Intern Med J 2010; 40:19-29.
  • Lin M, Chicco A. Letter 2: surgical management and outcomes of colorectal cancer liver metastases (Br J Surg 2010; 97: 1110-1118). Br J Surg 2010; 97:1743-4; author reply 4.